Litcius/Paper detail

Discovery of Hyperstable Noncanonical Plant-Derived Epidermal Growth Factor Receptor Agonist and Analogs

Shining Loo, Antony Kam, Binbin Li, Nan Feng, Xiao‐Liang Wang, James P. Tam

2021Journal of Medicinal Chemistry20 citationsDOIOpen Access PDF

Abstract

of the Cactaceae family. We show that bleogen pB1 is a low-affinity EGFR agonist using a suite of chemical, biochemical, cellular, and animal experiments which include incisor eruption and wound-healing mouse models. A focused positional scanning pB1 library of Ala- and d-amino acid scans yielded a high-affinity pB1 analog, [K29k]pB1, with a 60-fold-improved EGFR affinity and mitogenicity. We show that the potency of [K29k]pB1 and the epidermal growth factor (EGF) is comparable in a diabetic mouse wound-healing model. We also show that both bleogen pB1 and [K29k]pB1 are hyperstable, being >100-fold more stable than EGF against proteolytic degradation. Overall, our discovery of a noncanonical proteolytic-resistant EGFR agonist scaffold could open new avenues for developing wound healing and skin regeneration therapeutics and biomaterials.

Topics & Concepts

AgonistChemistryEpidermal growth factorWound healingEpidermal growth factor receptorReceptorPartial agonistCell biologyBiochemistryPharmacologyBiologyImmunologyBotanical Research and ApplicationsFungal Biology and ApplicationsBiochemical and Structural Characterization
Discovery of Hyperstable Noncanonical Plant-Derived Epidermal Growth Factor Receptor Agonist and Analogs | Litcius